Medtronic (MDT) stock in focus as the company wins FDA nod to integrate its MiniMed 780G insulin pump with Abbott's (ABT) ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with type 2 diabetes in the U.S., and allowing it to c | ...

The global Network Point-of-Care Glucose Testing Market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.8% ...

Afon Technology is pioneering advancements in diabetes care with GlucowearTM, the world’s first non-invasive, real-time, blood glucose monitor ...

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers.

“Existen muchas enfermedades crónicas relacionadas con la diabetes o con comorbilidades ... Stelo, lanzado el año pasado, es ...

The US Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management.

From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D).